£64.99
£64.99
Improved cancer survival has led to a new challenge: a rise in second primary cancers. As survivors live longer, understanding these malignancies is essential for follow-up care. This book provides insights into the epidemiology, risk factors, and management of these new cancers.
Cancer remains a major global health challenge and the second leading cause of death worldwide. Advances in therapy, early diagnosis, and screening have improved survival rates, leading to an increase in second primary cancers—new cancers that develop months or years after initial diagnosis and treatment. The rate of second primary cancers varies among different cancer types and has been steadily rising over recent decades. Factors such as predisposing genetics and treatments for primary cancers can increase the risk. As cancer survivors live longer, understanding secondary malignancies is essential for optimizing follow-up care and improving long-term outcomes. This book provides comprehensive insights into the epidemiology, risk factors, and management of second primary cancers in survivors.
This book uses solution-focused thinking to show how life with cancer may be lived well. Written in a chatty but powerfully effective style, it is for people who have cancer, their families, and friends, as well as the health professionals who seek to help them.
Public fear of breast cancer obscures the facts. Treatments can increase other health risks, while fear itself can impair quality of life. This book explores the history and mystery of breast cancer, from Ancient Egypt to the future, to champion the totality of women’s health.
This book highlights the usefulness of magnetic resonance imaging (MRI) for lung and thoracic tumors. Economical and with no radiation exposure, MRI offers advantages over CT and PET-CT, allowing for qualitative analysis of disease and early assessment of therapeutic effects.
The next generation of oncological hyperthermia selectively heats malignant cells. Due to its selectivity, this innovative concept is safer, less toxic, and uses significantly lower energy. This book shows the challenges, theoretical basis, and clinical results of the method.
As gynaecological cancer survival rates improve, quality of life after treatment is vital. This is the first textbook on managing the physical and psychological effects of treatment. It is essential reading for gynaecological oncology specialists and related disciplines.
This book provides a historical and applicable overview of current Interventional Oncology (IO) approaches. It explores treatment options, medical breakthroughs, and the disease processes themselves. This up-to-date review is crucial for learners and current interventionalists.
Learn how electrical pulses can make cancer treatment more efficient with fewer side effects. Successfully used with chemotherapy on over 3000 patients, this method doesn’t require high-tech resources, making it ideal for less-equipped healthcare settings.
This book describes the latest knowledge on hereditary colorectal cancer syndromes, focusing on management, surveillance, and screening. It discusses multidisciplinary care, risk estimation, genetic information, and future developments in this evolving field.
From a clinical pharmacist specializing in oncology, this book illuminates the fundamental aspects of solid and blood cancers and their novel drug therapies. Emphasizing key concepts, it provides a clear introduction for clinicians and students to understand oncology principles.
This volume covers cancer epidemiology, drug development, and therapies, presenting tools to assess side effects. It also explores patient quality of life, palliative care, and the global disparities that prevent equal access to diagnosis and treatment.
Processing Your Order
Please wait while we securely process your order.
Do not refresh or leave this page.
You will be redirected shortly to a confirmation page with your order number.
